Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Daniel Willis

Advertisement
Set Alert for Articles By Daniel Willis

Latest From Daniel Willis

GALVmed receives funding approval for Tryps Phase 3 program

GALVmed has received funding totaling $19 million for its Improved Tools for the Control of Animal African Trypanosomosis, Phase 3 (Tryps 3) program.

Pharmaceuticals R&D

Ouro Fino records highest stock valuation since March

Ouro Fino Saúde Animal has recorded its highest share price since March earlier this year, following third-quarter double-digit growth.

Ouro Fino Saude Animale

MSD expands Paracox vaccine supply with new manufacturing facility

MSD Animal Health has strengthened its UK market by opening a new manufacturing, packaging and warehousing facility in Milton Keynes.

Merck MSD Animal Health Vaccines

Delacon launches feed additive to address post-weaning challenges

Delacon has launched Fresta Protect, which is a phytogenic feed additive to address post-weaning challenges for piglets.

Feed & Additives Porcine

Ghanaian animal health start-up receives $300,000 funding

Ghanaian animal health start-up Cowtribe has received $300,000 funding from Draper Richards Kaplan – an American foundation that funds early-stage companies in Africa.

Investments Bovine

Virbac shares highest for over a year

Virbac has recorded its highest stock valuation in over a year – trading at a price of 147.40 ($166.38) per share on November 9, 2018.

Virbac
See All
Advertisement
UsernamePublicRestriction

Register